Mumbai, May 5 (Udaipur Kiran): Shelter Pharma is currently trading at Rs. 30.60, up by 0.22 points or 0.72% from its previous closing of Rs. 30.38 on the BSE.
The scrip opened at Rs. 30.00 and has touched a high and low of Rs. 30.60 and Rs. 30.00 respectively. So far 6000 shares were traded on the counter.
The BSE group ‘M’ stock of face value Rs. 10 has touched a 52 week high of Rs. 50.00 on 25-Aug-2025 and a 52 week low of Rs. 26.50 on 30-Mar-2026.
Last one week high and low of the scrip stood at Rs. 31.20 and Rs. 29.00 respectively. The current market cap of the company is Rs. 51.18 crore.
The promoters holding in the company stood at 44.99%, while non-institutions held 55.01% stake in the company.
Shelter Pharma has received repeat international purchase orders from an existing overseas customer, Taha Drugs & Chemicals Co in the normal course of business. The company has received purchase orders for supply of nutraceutical products.
These repeat orders reflect continued trust and satisfaction of the customer in the company’s products and services and signify strengthening business relations in the international market. The development is expected to further enhance the company’s global presence and contribute positively to its revenue and overall business growth. Broad commercial consideration or size of the orders is $84,450. The orders are to be executed within the mutually agreed timelines as per purchase order and shipment schedule.
Shelter Pharma is engaged in the business of manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
